Clinical trials: Glucocorticoid-Associated Osteopenia and Osteoporosis
Osteopenia, Osteoporosis
Network Osteoporosis Study
This study is evaluating the use of the drug alendronate in preventing or reversing bone loss in children and adolescents receiving steroid medications.
- Trial name
- NCT00209469
- Testing
- alendronate sodium
- Where
- 4 sites in United States
- Volunteers
- 90 people
- Sponsor
- Glaser Pediatric Research Network
Glucocorticoid-Associated Osteopenia and Osteoporosis
Alendronate Osteoporosis Study
This trial will test the hypothesis that among 20 children and adolescents from Children's Hospital, Boston with Crohn's disease, ulcerative colitis, systemic-onset juvenile rheumatoid arthritis, juvenile dermatomyositis…
- Trial name
- NCT00277251
- Testing
- Alendronate
- Volunteers
- 20 people
- Sponsor
- Boston Children's Hospital
Glucocorticoid-Associated Osteopenia and Osteoporosis
Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years
This is an extended observation study of a RCT comparing the efficacy of romorozumab and denosumab in high-risk patients using long-term glucocorticoids.
- Trial name
- NCT07757373
- Testing
- Romosozumab, Denosumab
- Where
- Hong Kong
- Volunteers
- 54 people
- Sponsor
- Tuen Mun Hospital